Cancer Treatment Results  Survival Rates Cancer Treatments / Therapy Results
Cancer
 
Search Results



Your search returned 1870 record(s).

Page 133 of 187  |  Previous Page   |  Next Page

Cancer Type:   Sort By:

This Search was Made Possible by:


  Survival: Patients: Toxicity: Treatment: Hospital: Country: Date:
1321 9.2 months Advanced hepatocellular carcinoma 4 Alternative
Chemotherapy
City of Hope National Medical Center United States 10/2009
Treatment Details: Patients: This phase 2 study involved 31 advanced hepatocellular patients. The median patient age was 60 years and 93.5% were male. Treatment: Patients were treated with the chemothera
 
1322 9.2 months Metastatic Colorectal Cancer 4 Chemotherapy
Seoul National University Bundang Hospital Korea 9/2014
Treatment Details: Patients: This phase 2 study involved 41 metastatic colorectal cancer patients who had been previously treated with fluoropyrimidine, oxaliplatin and irinotecan. The median patient age was
 
1323 9.2 months Advanced Liver Cancer 5 Biologic therapy
Massachusetts General Hospital Cancer Center United States 7/2015
Treatment Details: Patients: This phase 3 study involved 283 advanced hepatocellular carcinoma patients who were previously treated with sorafenib. The median patient age was 64 years and 83% were male. Tr
 
1324 9.1 months Metastatic Prostate Cancer 5 Biologic therapy
Chemotherapy
University of Michigan United States 10/2014
Treatment Details: Patients: This study involved 26 metastatic castration-resistant prostate cancer patients who had been previously treated with docetaxel. The median patient age was 67.0 years. Treatmen
 
1325 9.1 months Recurrent Ovarian Cancer 3 Immunotherapy
University of Alabama School of Medicine United States 6/2014
Treatment Details: Patients: This phase 2 study involved 20 recurrent epithelial ovarian, fallopian tube or primary peritoneal cancer patients who had received prior platinum-based chemotherapy. The median p
 
1326 9.1 months Non-Sqaumous NSCLC 5 Chemotherapy
David Geffen School of Medicine at UCLA United States 8/2014
Treatment Details: Patients: This phase 3 study involved non-small cell lung cancer patients who had received prior platinum-based chemotherapy and were divided into two separate treatment groups. Group A co
 
1327 9.1 months Advanced NSCLC 5 Biologic therapy
Institut Gustave Roussy France 2/2014
Treatment Details: Patients: This phase 2 study involved previously treated advanced non-small cell lung cancer patients who were divided into two treatment groups. In group A, there were 66 patients with a
 
1328 9.1 months Newly diagnosed GBM 3 Chemotherapy
Radiation
Dartmouth-Hitchcock Medical Center United States 12/2000
Treatment Details: Patients: This Phase II study involved 108 patients with newly diagnosed glioblastoma multiforme. (Only 104 were “analyzable.”) Patients were divided into two groups – 55 patients in Group
 
1329 9.1 months Metastatic melanoma 5 Chemotherapy
Memorial Sloan-Kettering Cancer Center United States 6/2011
Treatment Details: Patients: In this study, patients with previously untreated metastatic melanoma were divided into 2 separate treatment groups. Group A consisted of 250 patients with a median age of 57.5 y
 
1330 9.1 months Melanoma 5 Chemotherapy
University of Nottingham United Kingdom 5/2011
Treatment Details: Patients: This phase III study involved stage IV melanoma patients who were divided into two separate treatment groups. Group A included 429 patients, 64% of whom were over the age of 65 y
 
Page 133 of 187  | Previous Page  | Next Page